H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 87 Citations 26,014 601 World Ranking 6816 National Ranking 240

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Neuroscience

His primary areas of study are Neuroscience, Amyotrophic lateral sclerosis, Transcranial magnetic stimulation, Internal medicine and Frontotemporal dementia. His research brings together the fields of Depolarization and Neuroscience. His study in Amyotrophic lateral sclerosis is interdisciplinary in nature, drawing from both Neuromuscular disease and Neurodegeneration.

The various areas that Matthew C. Kiernan examines in his Transcranial magnetic stimulation study include Evoked potential, Compound muscle action potential, Inhibitory postsynaptic potential and Degenerative disease. The Internal medicine study combines topics in areas such as Peripheral neuropathy, Endocrinology, Surgery, Oncology and Cardiology. His Frontotemporal dementia study also includes fields such as

  • Psychiatry that connect with fields like Cohort,
  • Family history and related Blood sampling.

His most cited work include:

  • Multiple measures of axonal excitability: A new approach in clinical testing (385 citations)
  • Clinical diagnosis and management of amyotrophic lateral sclerosis (368 citations)
  • Controversies and priorities in amyotrophic lateral sclerosis (356 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Amyotrophic lateral sclerosis, Neuroscience, Internal medicine, Disease and Transcranial magnetic stimulation. His Amyotrophic lateral sclerosis research integrates issues from Cognition, Pathophysiology, Physical medicine and rehabilitation and Frontotemporal dementia. His work deals with themes such as Neurodegeneration and Depolarization, which intersect with Neuroscience.

His research investigates the link between Internal medicine and topics such as Peripheral neuropathy that cross with problems in Kidney disease. Matthew C. Kiernan combines subjects such as Clinical trial and Intensive care medicine with his study of Disease. His Transcranial magnetic stimulation research is multidisciplinary, incorporating perspectives in Motor cortex, Threshold tracking and Evoked potential.

He most often published in these fields:

  • Amyotrophic lateral sclerosis (52.86%)
  • Neuroscience (46.89%)
  • Internal medicine (36.30%)

What were the highlights of his more recent work (between 2018-2021)?

  • Amyotrophic lateral sclerosis (52.86%)
  • Internal medicine (36.30%)
  • Disease (20.71%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Amyotrophic lateral sclerosis, Internal medicine, Disease, Neuroscience and Frontotemporal dementia. His study in Amyotrophic lateral sclerosis is interdisciplinary in nature, drawing from both Disease progression, Genetics, Clinical trial, Transcranial magnetic stimulation and Cognition. His work carried out in the field of Internal medicine brings together such families of science as Peripheral neuropathy, Oncology and Cardiology.

While the research belongs to areas of Disease, he spends his time largely on the problem of Intensive care medicine, intersecting his research to questions surrounding MEDLINE. His research in Neuroscience intersects with topics in Neuroinflammation and Neurodegeneration. The study incorporates disciplines such as Endocrinology, Putamen, Pathological and Atrophy in addition to Frontotemporal dementia.

Between 2018 and 2021, his most popular works were:

  • Neuroinflammation in frontotemporal dementia. (49 citations)
  • Neuroinflammation in frontotemporal dementia. (49 citations)
  • Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders. (46 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Neuroscience

Matthew C. Kiernan mostly deals with Amyotrophic lateral sclerosis, Internal medicine, Neuroscience, Frontotemporal dementia and Disease. His Amyotrophic lateral sclerosis research includes themes of Transcranial magnetic stimulation, Clinical trial, Disease progression and Intensive care medicine. His research integrates issues of Endocrinology and Cardiology in his study of Internal medicine.

His Neuroscience research incorporates elements of Neuroinflammation, Nerve membrane, Neurodegeneration and Dementia. His studies deal with areas such as Pathological, Neuropsychology, Proteomics, Putamen and Atrophy as well as Frontotemporal dementia. His Disease study combines topics from a wide range of disciplines, such as Precision medicine, Immunology, Blood proteins, S100A8 and Calcium ion binding.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical diagnosis and management of amyotrophic lateral sclerosis

Orla Hardiman;Leonard H. van den Berg;Matthew C. Kiernan.
Nature Reviews Neurology (2011)

549 Citations

Controversies and priorities in amyotrophic lateral sclerosis

Martin R Turner;Orla Hardiman;Michael Benatar;Benjamin R Brooks.
Lancet Neurology (2013)

504 Citations

Chemotherapy-induced peripheral neurotoxicity: a critical analysis.

Susanna B. Park;David Goldstein;Arun V. Krishnan;Cindy S‐Y Lin.
CA: A Cancer Journal for Clinicians (2013)

480 Citations

Biomarkers in amyotrophic lateral sclerosis.

Martin R Turner;Matthew C Kiernan;P Nigel Leigh;Kevin Talbot.
Lancet Neurology (2009)

457 Citations

Multiple measures of axonal excitability: A new approach in clinical testing

Matthew C. Kiernan;David Burke;Kjeld V. Andersen;Hugh Bostock.
Muscle & Nerve (2000)

456 Citations

Excitability of human axons.

D Burke;MC Kiernan;H Bostock.
Clinical Neurophysiology (2001)

427 Citations

Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis

Steve Vucic;Garth A. Nicholson;Matthew C. Kiernan.
Brain (2008)

381 Citations

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

Wouter van Rheenen;Aleksey Shatunov;Annelot M. Dekker;Russell L. McLaughlin.
Nature Genetics (2016)

360 Citations

Guillain-Barré syndrome: an update.

Steve Vucic;Steve Vucic;Matthew C. Kiernan;David R. Cornblath.
Journal of Clinical Neuroscience (2009)

359 Citations

Strength-duration properties of human peripheral nerve

Ilona Mogyoros;Matthew C. Kiernan;David Burke.
Brain (1996)

323 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Matthew C. Kiernan

Orla Hardiman

Orla Hardiman

Trinity College Dublin

Publications: 108

Satoshi Kuwabara

Satoshi Kuwabara

Chiba University

Publications: 100

David Burke

David Burke

Royal Prince Alfred Hospital

Publications: 95

Martin R. Turner

Martin R. Turner

University of Oxford

Publications: 92

Albert C. Ludolph

Albert C. Ludolph

University of Ulm

Publications: 83

John R. Hodges

John R. Hodges

University of Sydney

Publications: 81

Leonard H. van den Berg

Leonard H. van den Berg

Utrecht University

Publications: 78

Ammar Al-Chalabi

Ammar Al-Chalabi

King's College London

Publications: 77

Peter Bede

Peter Bede

Trinity College Dublin

Publications: 69

Olivier Piguet

Olivier Piguet

University of Sydney

Publications: 60

Glenda M. Halliday

Glenda M. Halliday

University of Sydney

Publications: 59

Michael Swash

Michael Swash

Queen Mary University of London

Publications: 59

Hugh Bostock

Hugh Bostock

University College London

Publications: 58

Adriano Chiò

Adriano Chiò

University of Turin

Publications: 57

Pamela J. Shaw

Pamela J. Shaw

University of Sheffield

Publications: 55

Guido Cavaletti

Guido Cavaletti

University of Milano-Bicocca

Publications: 41

Something went wrong. Please try again later.